iCure, Top Search Ranking... Stock Price Up 2.01%
IQor recently ranked among the top searched stocks on 4 days within the past month.
As of 11:30 AM on the 10th, IQor is trading at 60,800 KRW, up 2.01% from the previous day. This is a 23.52% decrease compared to December 7. IQor is known as a company possessing core technology in transdermal drug delivery systems.
Over the past 5 days, individual investors have net purchased 23,432 shares, while foreigners and institutions have net purchased 31,117 shares and net sold 19,762 shares, respectively.
On December 9, IQor was a market issue with the headline "Two consecutive days of decline due to disappointment at the general shareholders' meeting."
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- Brilliant Korean Technology Flows Overseas... Subsidies Granted, but "No Product Launch Allowed"
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- Singer Kim Minjong Responds to MC Mong's Gambling Allegations: "Clearly False... Legal Action to Follow"
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"

※Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.